The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
Reasoning
The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
Cite this ruling
CBP Ruling N242521 (3004909140): The tariff classification of Buspirone Hydrochloride Tablets, Pramipexole Dihydrochloride Extended Release Tablets, Minocycline Hydrochloride Extended Release Tablets, imported in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Cinacalcet Hydrochloride Tablets in dosage form, from India
The tariff classification of Albuterol Tablets and Azelastine Hydrochloride Nasal Spray in dosage form, from India
The tariff classification of Albuterol Tablets and Azelastine Hydrochloride Nasal Spray in dosage form, from India
The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India